SCHEMBL6199262

SCHEMBL6199262

O=c1ccn(CCO)c(C(O)c2cccc(F)c2)c1O

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
IGFBP3 P17936 1/20 0.34
IDO1 P14902 1/20 0.34
TDO2 P48775 1/20 0.34
TEAD4 Q15561 1/20 0.34
SLC6A2 P23975 5/20 0.33
SLC6A4 P31645 5/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33
ALOX12 P18054 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6196542 0.85 KMT2A (0.33) IDO1TDO2TEAD4KDM4EALDH1A1
SCHEMBL6199826 0.81 UGT2B7 (0.37) TEAD4SLC6A2SLC6A4KDM4EMAPT
SCHEMBL6198019 0.80 SMN1; SMN2 (0.45) SLC6A2SLC6A4ALDH1A1
SCHEMBL6198424 0.78 SMN1; SMN2 (0.42) TEAD4SLC6A2SLC6A4KDM4EALDH1A1
SCHEMBL6195639 0.78 KDM4E (0.35) CES2CES1IDO1TDO2TEAD4
SCHEMBL6196517 0.77 FPR2 (0.33) TEAD4KDM4E
SCHEMBL6196493 0.77 KDM4E (0.34) IDO1TDO2KDM4EALDH1A1LMNA
SCHEMBL6193968 0.75 TSHR (0.47) GAAMAPT
Alcohol SCHEMBL8928372 0.75 KDM4E (0.36) CES2CES1IDO1TDO2TEAD4
SCHEMBL6198566 0.74 KDM4E (0.37) KDM4ELMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0768302-B1 Hydroxypyridinones NOVARTIS AG (CH) 2005-07-06 EP disclosed
US-5688815-A COMPOUNDS FOR REMOVAL OF EXCESS IRON IN MAMMALS CIBA GEIGY CORPORATION (US) 1997-11-18 US disclosed
EP-0768302-A2 Hydroxypyridinones Novartis AG (CH) 1997-04-16 EP disclosed